Production of Levan, A Potential Low Calorie Sweetener From Low Cost Substrates
Abstract
Levan is a biocompatible and bioactive bio-polymer with good rheological and medicinal properties. Due to its high cost, it is beyond reach of commons. The current study deals with levan production using regional low cost substrates as carbon source which will help to reduce its cost. 10 isolates were obtained from a novel source i.e. soil from jaggery preparation area, from which three levan producing isolates were selected and identified by 16S rRNA gene sequencing as Bacillus xiamenensis (JX680066), Bacillus subtilis (KC243314) and Bacillus subtilis (DQ922949). These three isolates produced levan 80.3 g/L, 79.6 g/L and 81.4 g/L respectively. Levan production with molasses was much higher than the levan production using sucrose. Levan obtained from Bacillus subtilis (DQ922949) was purified and further analyzed by NMR and HPLC. Toxicological studies showed it is non- toxic to living cells.
Key words: Bioactive, molasses, jaggery field, Bacillus subtilis (DQ922949), cytotoxicity.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |